Diminished suppressor cell function in patients with asbestosis

H R Gaumer, N J Doll, J Kaimal, M Schuyler, J E Salvaggio, H R Gaumer, N J Doll, J Kaimal, M Schuyler, J E Salvaggio

Abstract

Epidemiological and immunological studies of asbestos workers documented abnormalities in humoral and cell-mediated immunity which could result from defective immunoregulation. This study tests this hypothesis with comparison of lymphocyte function in age-, sex- and smoking-matched subjects with asbestosis. In vivo measure of delayed hypersensitivity (i.e. skin test response) was significantly depressed to two recall antigens, SKSD and Candida, in asbestosis patients. Skin reaction to dinitrochlorobenzene (DNCB) was not depressed, although lymphocytes of patients giving positive skin test reactions demonstrated a significantly lower (P less than 0.001) proliferative response to dinitrobenzene sulphonic acid (DNBSO3) in vitro. T cell counts (E-rosettes) were normal in patients with asbestosis, although a subset of T cells, those forming sheep erythrocyte rosettes after prolonged incubation (Elate), were significantly depressed (P less than 0.003). This population has been equated with 'suppressor' cells (Grossi et al., 1978). Numbers of B cells were increased nearly two-fold over controls. Mitogen response of lymphocytes was normal except at suboptimal doses of mitogens where the response is known to be influenced by suppressor cell activity, which was significantly elevated. Suppressor cell function, as determined by stimulation of peripheral blood lymphocytes preincubated with concanavalin A, was also significantly decreased in asbestosis patients (P less than 0.01).

References

    1. Ann N Y Acad Sci. 1965 Dec 31;132(1):112-20
    1. Thorax. 1958 Sep;13(3):185-93
    1. Am J Clin Pathol. 1970 Feb;53(2):204-8
    1. Br Med J. 1970 Aug 29;3(5721):492-5
    1. N Engl J Med. 1972 Feb 24;286(8):399-402
    1. Am Ind Hyg Assoc J. 1971 Sep;32(9):599-602
    1. J Clin Invest. 1972 Oct;51(10):2537-43
    1. J Immunol. 1974 Feb;112(2):849-51
    1. Int Arch Arbeitsmed. 1974 Jan 31;32(4):313-25
    1. J Exp Med. 1976 May 1;143(5):1100-10
    1. J Reticuloendothel Soc. 1976 Aug;20(2):159-70
    1. Eur J Immunol. 1976 Jun;5(6):432-5
    1. J Immunol. 1976 Dec;117(6):2158-64
    1. Nature. 1976 Dec 2;264(5585):444-6
    1. J Immunol. 1977 Jun;118(6):2004-8
    1. Clin Exp Immunol. 1977 May;28(2):261-7
    1. Clin Exp Immunol. 1977 May;28(2):268-75
    1. J Allergy Clin Immunol. 1977 Oct;60(4):218-22
    1. J Exp Med. 1978 May 1;147(5):1405-17
    1. Br J Exp Pathol. 1978 Apr;59(2):183-9
    1. Cancer Lett. 1979 Apr;6(4-5):183-92
    1. Arch Environ Health. 1979 May-Jun;34(3):133-40
    1. Am J Med. 1979 Aug;67(2):325-30
    1. J Allergy Clin Immunol. 1979 Oct;64(4):294-8
    1. Int Arch Allergy Appl Immunol. 1980;61(1):28-31
    1. Clin Exp Immunol. 1979 Nov;38(2):323-31
    1. Clin Immunol Immunopathol. 1980 Jan;15(1):106-22
    1. J Immunol. 1980 Mar;124(3):1403-10
    1. Clin Exp Immunol. 1980 Jan;39(1):176-82
    1. Arch Environ Health. 1966 Nov;13(5):619-21

Source: PubMed

3
Sottoscrivi